Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1711 (LINC01711)

Target
LINC01711
Molecular classification
Other (Long non-coding RNA, lncRNA)
01

Overview

Long intergenic non-protein coding RNA 1711 (LINC01711) is a long non-coding RNA (lncRNA) that does not code for protein but plays regulatory roles in gene expression, particularly by functioning as a competing endogenous RNA that sponges microRNAs. Elevated LINC01711 expression has been observed in several cancers, including glioblastoma and breast cancer, where it promotes tumor cell proliferation, migration, invasion, and may confer resistance to apoptosis. Mechanistically, LINC01711 acts by sequestering microRNAs such as miR-34a and miR-4510, thereby upregulating downstream effectors like ZEB1 and NELFE, leading to changes in cancer cell behavior. High levels of LINC01711 are associated with poor prognosis in glioblastoma and possibly other malignancies, suggesting its potential utility as both a biomarker and a therapeutic target.

Other names
MGC4294LINC01711
02

Mechanism of action

miRNA sponge (competes with miR-34a and miR-4510, regulating ZEB1 and NELFE-dependent pathways)

03

Biological functions

Competing endogenous RNA activity (miRNA sponge)Regulation of gene expressionPromotion of cell proliferationEnhancement of cell migration and invasion
04

Disease associations

Cancer (notably glioblastoma and breast cancer)
05

Safety considerations

No specific safety concerns or therapeutic challenges have been widely reported. However, as with most lncRNAs implicated in cancer, targeting specificity and delivery may be challenges in therapeutic development
06

Interacting drugs

Temozolomide
07

Biomarkers

High LINC01711 expression as a prognostic biomarker for poor survival in glioblastoma

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1711 (LINC01711).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1711 (LINC01711).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call